Orchestra BioMed Holdings, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Orchestra BioMed Holdings, Inc. (OBIO) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $1.20 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-03-12
- Orchestra BioMed Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-12-31 was $537.00K.
- Orchestra BioMed Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $1.20M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|
| 2024-12-31 | $537.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.20M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $665.00K 10-Q · filed 2025-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |